Patents by Inventor Tingjin Wang
Tingjin Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11751512Abstract: The present application discloses a woody rootstock for efficient grafting of solanaceous vegetables and an efficient grafting and seedling culture method thereof. According to the present application, a woody rootstock clone with high consistency is provided through tissue culture, efficient grafting is completed through sleeve grafting technology, and the grafting survival rate is improved by regulating the healing environment. A new idea for efficient industrial grafting of solanaceous vegetables is provided, scions are imparted with new features through distant grafting, and the problems of low grafting efficiency and low survival rate are solved. The method has the advantages of strong operability, simplicity, high efficiency and low cost, and provides a technical support for the industrial production of grafted seedlings of solanaceous vegetables.Type: GrantFiled: October 11, 2021Date of Patent: September 12, 2023Assignee: ZHEJIANG UNIVERSITYInventors: Liping Chen, Tingjin Wang, Lu Yuan, Ke Liu, Aijun Zhang, Yang Yang, Xuan Zhang, Yuzhuo Li, Zhenyu Qi
-
Publication number: 20230279024Abstract: The present invention relates to the field of medicine, and specifically relates to a triazine compounds as represented by formula (I), or a stereoisomer, a tautomer, a nitrogen oxide, a solvate, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing the compound, and use of the compound and the pharmaceutical composition thereof in the preparation of drugs for treating and/or preventing proliferative disease, autoimmune diseases, allergic diseases, inflammatory diseases, transplant rejection, cancers, viral infectious diseases, or other diseases in mammals. The compound provided by the present invention exhibits excellent inhibitory activity and kinase selectivity against a target kinase.Type: ApplicationFiled: July 9, 2021Publication date: September 7, 2023Applicant: BEIJING FINDCURE BIOSCIENCES, LTD.Inventors: Ning XI, Shimin XU, Tingjin WANG
-
Publication number: 20220022378Abstract: The present application discloses a woody rootstock for efficient grafting of solanaceous vegetables and an efficient grafting and seedling culture method thereof. According to the present application, a woody rootstock clone with high consistency is provided through tissue culture, efficient grafting is completed through sleeve grafting technology, and the grafting survival rate is improved by regulating the healing environment. A new idea for efficient industrial grafting of solanaceous vegetables is provided, scions are imparted with new features through distant grafting, and the problems of low grafting efficiency and low survival rate are solved. The method has the advantages of strong operability, simplicity, high efficiency and low cost, and provides a technical support for the industrial production of grafted seedlings of solanaceous vegetables.Type: ApplicationFiled: October 11, 2021Publication date: January 27, 2022Inventors: Liping CHEN, Tingjin WANG, Lu YUAN, Ke LIU, Aijun ZHANG, Yang YANG, Xuan ZHANG, Yuzhuo LI, Zhenyu QI
-
Patent number: 9657007Abstract: The invention relates to the preparation and use of new aminopyrimidine derivatives as drug candidates in free form or in pharmaceutically acceptable salt form and formulations thereof for the modulation of a disorder or disease which is mediated by the activity of the PI3K enzymes. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of disorders or diseases, such as disorders of immunity and inflammation in which PI3K enzymes play a role in leukocyte function, and hyperproliferative disorders associated with PI3K activity, including but not restricted to leukemias and solid tumors, in mammals, especially humans.Type: GrantFiled: September 17, 2014Date of Patent: May 23, 2017Assignees: CALITOR SCIENCES, LLC, SUNSHINE LAKE PHARMA CO., LTD.Inventors: Ning Xi, Liang Wang, Tingjin Wang
-
Publication number: 20170081338Abstract: The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof. They are useful in preventing, managing, treating or lessening the severity of a protein kinase-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.Type: ApplicationFiled: September 13, 2016Publication date: March 23, 2017Applicants: Sunshine Lake Pharma Co., Ltd., Calitor Sciences, LLCInventors: Ning Xi, Weilong Dai, Minxiong Li, Wuhong Chen, Tao Zhang, Haiyang Hu, Xiaobo Li, Jun Liu, Tingjin Wang
-
Patent number: 9512114Abstract: The invention relates to the preparation and use of new aminopyrimidine derivatives as drug candidates in free form or in pharmaceutically acceptable salt form and formulations thereof for the modulation of a disorder or disease which is mediated by the activity of the PI3K enzymes. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of disorders or diseases, such as disorders of immunity and inflammation in which PI3K enzymes play a role in leukocyte function, and hyperproliferative disorders associated with PI3K activity, including but not restricted to leukemias and solid tumors, in mammals, especially humans.Type: GrantFiled: March 15, 2015Date of Patent: December 6, 2016Assignees: CALITOR SCIENCES, LLC, SUNSHINE LAKE PHARMA CO., LTD.Inventors: Ning Xi, Liang Wang, Tingjin Wang
-
Publication number: 20160318914Abstract: The invention relates to the preparation and use of new aminopyrimidine derivatives as drug candidates in free form or in pharmaceutically acceptable salt form and formulations thereof for the modulation of a disorder or disease which is mediated by the activity of the PI3K enzymes. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of disorders or diseases, such as disorders of immunity and inflammation in which PI3K enzymes play a role in leukocyte function, and hyperproliferative disorders associated with PI3K activity, including but not restricted to leukemias and solid tumors, in mammals, especially humans.Type: ApplicationFiled: March 15, 2015Publication date: November 3, 2016Applicants: Calitor Sciences, LLC, Sunshine Lake Pharma Co., Ltd.Inventors: Ning Xi, Liang Wang, Tingjin Wang
-
Patent number: 9399639Abstract: The present invention provides substituted azaindole prodrugs, methods of making said prodrugs, pharmaceutical compositions of said prodrugs and methods of using said prodrugs and pharmaceutical compositions thereof to treat or prevent diseases or disorders such as cancer.Type: GrantFiled: August 26, 2013Date of Patent: July 26, 2016Assignees: CALITOR SCIENCES, LLC, SUNSHINE LAKE PHARMA CO., LTD.Inventors: Ning Xi, Tingjin Wang, Yin Tang, Mingming Sun, Qian Wang
-
Patent number: 9394281Abstract: The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof useful in preventing, treating or lessening the severity of a protein kinase-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.Type: GrantFiled: March 27, 2015Date of Patent: July 19, 2016Assignees: CALITOR SCIENCES, LLC, SUNSHINE LAKE PHARMA CO., LTD.Inventors: Ning Xi, Minxiong Li, Xiaobo Li, Weilong Dai, Tingjin Wang
-
Publication number: 20150274747Abstract: The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof useful in preventing, treating or lessening the severity of a protein kinase-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.Type: ApplicationFiled: March 27, 2015Publication date: October 1, 2015Applicants: Calitor Sciences, LLC, Sunshine Lake Pharma Co., Ltd.Inventors: Ning Xi, Minxiong Li, Xiaobo Li, Weilong Dai, Tingjin Wang
-
Publication number: 20150087658Abstract: The invention relates to the preparation and use of new aminopyrimidine derivatives as drug candidates in free form or in pharmaceutically acceptable salt form and formulations thereof for the modulation of a disorder or disease which is mediated by the activity of the PI3K enzymes. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of disorders or diseases, such as disorders of immunity and inflammation in which PI3K enzymes play a role in leukocyte function, and hyperproliferative disorders associated with PI3K activity, including but not restricted to leukemias and solid tumors, in mammals, especially humans.Type: ApplicationFiled: September 17, 2014Publication date: March 26, 2015Applicants: CALITOR SCIENCES, LLC, SUNSHINE LAKE PHARMA CO., LTD.Inventors: Ning Xi, Liang Wang, Tingjin Wang
-
Publication number: 20140056849Abstract: The present invention provides substituted azaindole prodrugs, methods of making said prodrugs, pharmaceutical compositions of said prodrugs and methods of using said prodrugs and pharmaceutical compositions thereof to treat or prevent diseases or disorders such as cancer.Type: ApplicationFiled: August 26, 2013Publication date: February 27, 2014Applicants: Sunshine Lake Pharma Co., Ltd., Calitor Sciences, LLCInventors: Ning Xi, Tingjin Wang, Yin Tang, Mingming Sun, Qian Wang